American Association for Cancer Research (AACR) Annual Meeting 2019

American Association for Cancer Research (AACR) Annual Meeting is organized by American Association for Cancer Research (AACR) and will be held from Mar 29 - Apr 03, 2019 at Georgia World Congress Center, Atlanta, Georgia, United States of America.

The target audience for this medical event iscancer biologists, clinical oncologists, and population scientists with engineers, computational biologists, and physical scientists to develop quantitative approaches and ask new questions to develop better strategies for curing cancer. This CME Conference has been approved for a maximum of 47.0 AMA PRA Category 1 Credit(s)™.

Statement of Educational Need:
The fight against cancer is rapidly progressing with the accelerating pace of discoveries in the basic, translational, and clinical sciences. This is due in large part to the advent of new technologies, such as advanced live imaging techniques and liquid biopsies, and our increased understanding of the importance of harnessing the power of the immune system to develop new immunotherapies. However, understanding and combating the processes of cancer initiation, progression, and response to treatment require a multidisciplinary approach.

The AACR Annual Meeting brings together cancer biologists, clinical oncologists, and population scientists with engineers, computational biologists, and physical scientists to develop quantitative approaches and ask new questions to develop better strategies for curing cancer. By bridging the gap between what physicians understand about cancer biology and the clinical applications, this meeting aids basic researchers, physicians, and clinician-scientists in obtaining, synthesizing, and integrating the most current molecular-based tests to aid in the diagnosis, treatment, and prevention of cancer.

Further, facilitating the interface between physicians and scientists increases the contributions of laboratory research to drug development as well as patient care, transforms the design and conduct of clinical research protocols, and creates an avenue for the rapid translation of laboratory research findings from “bench-to-bedside” for the benefit of improving patient outcomes. This meeting also acts as a forum to discuss cancer health disparities and help ensure that all patients benefit from emerging breakthroughs in research and cancer treatment.

Learning Objectives:
After participating in this CME activity, physicians should be able to:
• Assess the technological advances and tools, such as liquid biopsies, being used to accelerate progress in cancer research and improve early detection and the early interception, with the ultimate goal of extending patients' lives and improving their quality of life.
• Articulate how advances in precision cancer medicine are leading to improved patient outcomes.
• Incorporate the latest research findings regarding therapies and treatment options, including immunotherapy and combination therapies, in a variety of cancer types to improve patient outcomes.
• Formulate new strategies integrating multidisciplinary scientific and clinical research efforts towards the prevention, early detection, and interception of cancer.
• Identify factors that impact the diagnosis, treatment, and prevention of various forms of cancers in patients from diverse populations.
• Develop collaborations among physicians, researchers, and clinician-scientists to advance approaches for cancer treatment and prevention.